Endeeper and Carl Zeiss of Brazil Establish Agreement for Sale of Products in Geology
September 17, 2012
Porto Alegre, RS -- Endeeper, recognized provider of software and services for knowledge management and data integration of geological data, announced the establishment of a long-term representation agreement with Carl Zeiss of Brazil, the world leader in optics and optoelectronics industries. The commercial agreement defined the Carl Zeiss of Brazil as the exclusive representative of [...]
September 17, 2012
BILLERICA, Mass -- EMD Millipore, the Life Science division of Merck KGaA of Darmstadt, Germany, and iPS Academia Japan, Inc. (Kyoto, Japan) today announced a global licensing agreement for AJ’s induced pluripotent stem (iPS) cell patent portfolio. The non-exclusive agreement provides EMD Millipore the opportunity to continue to develop and ultimately commercialize iPS cells for [...]
September 17, 2012
Freeslate, Inc.,the leading provider of high throughput research solutions, today announced the release of LEA 8.4. Building on over 12 years of successful customer deployments and feedback, Freeslate LEA 8.4 provides an improved user experience in designing experiments by significantly reducing manual entry and providing integration with DOE software and customer chemical inventory databases. Freeslate [...]
Life Technologies to Partner with Bristol-Myers Squibb for Companion Diagnostics Development
September 17, 2012
CARLSBAD, Calif., -- Life Technologies Corporation (NASDAQ:LIFE - News) today announced that the company has entered into a Master Development Agreement with Bristol-Myers Squibb Company (NYSE:BMY) for current and future companion diagnostics projects. The current agreement constitutes the second collaboration between the two companies and represents another step in Life Technologies' strategy to develop its [...]
BioDiscovery and AGRE Enter into a Co-Promotion Agreement
September 17, 2012
HAWTHORNE, CA AND LOS ANGELES, CA -- BioDiscovery, Inc. a leader in integrated software solutions for genomic-based research, and the Autism Genetic Resource Exchange (AGRE), a program of Autism Speaks, which collects and houses genetic and phenotypic data on over 1300 families with autism, have signed a co-promotion agreement. This agreement allows AGRE to provide [...]
Synthetic Genomics Inc. Purchases Patent Portfolio from Febit Holding GmbH
September 17, 2012
LA JOLLA, CA —— Synthetic Genomics Inc. (SGI), a privately held company developing and commercializing genomic-driven solutions to solve a range of global challenges, today announced they have purchased from Febit Holding GmbH the worldwide rights to three families of patents and patent applications related to key synthetic genomic technologies. All related know-how, equipment and [...]
Roche cytomegalovirus viral load test now available in US
September 17, 2012
INDIANAPOLIS, -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today the commercial availability of a new test to assess a patient's viral load of cytomegalovirus (CMV). Physicians use information from the test to help them manage patients who have been diagnosed with CMV disease, specifically patients with an immune system that has been suppressed for [...]
AB SCIEX Announces Biologics Initiative
September 17, 2012
FRAMINGHAM, Mass.-- AB SCIEX, a global leader in life science analytical technologies, today announced a global initiative focused on biologics. This new initiative is in response to the fundamental shift of the pharmaceutical industry into biopharmaceutical development. AB SCIEX’s BiologicsFocus Initiative consists of four components: new product development; beta software evaluation program; one-on-one connections program; [...]
Bruker Ushers in New Era of eXtreme Resolution (XR™) in Mass Spectrometry
September 16, 2012
KYOTO, Japan -- At the 19th International Mass Spectrometry Conference (https://www.imsc2012.jp), Bruker today introduced the breakthrough new solariX XR Fourier Transform Mass Spectrometer (FTMS) with the revolutionary ParaCell™ for extreme mass resolution greater than 10 million. This level of eXtreme Resolution (XR™) represents an order of magnitude quantum jump in mass resolving power, and opens [...]
September 16, 2012
Agilent Technologies Inc. (NYSE: A) today announced that it has entered into a comarketing agreement with Molecular Discovery Ltd. to provide biopharmaceutical researchers with an advanced metabolite-identification platform. The companies will comarket the combined assets of Agilent's high-resolution liquid chromatography/mass spectrometry (LC/MS) technology and Molecular Discovery's Mass-MetaSite software to enable superior identification and analysis of [...]

